ANGPT1 and neoplasm: We demonstrated tunability of the vascular permeability through treatment of ECs with angiopoietin 1 (Ang-1) and a cell membrane permeable form of cyclic adenosine monophosphate (pCPT-cAMP) to approximate both healthy and tumor vascular permeability.